Posted in | News | Mining Business | Alumina

Imperial Mining and Albecour Sign MOU to Produce Scandium-Aluminum Alloys

Imperial Mining Group Ltd. ("Imperial") and partner Albecour Inc. (“Albecour” and, collectively with Imperial, the “Parties), are pleased to announce that they have signed a Memorandum of Understanding (“MOU”) to investigate the potential of producing specialty Scandium-Aluminum alloys in the Province of Québec.

Under the terms of the MOU, the Parties intend to evaluate, and if deemed commercially viable, enter into a commercial agreement for the manufacturing of Scandium-Aluminum master alloys with an aluminum production plant to be identified by the Parties (the “Project”).

“We are pleased to be working with Albecour to develop specialty Scandium-Aluminum alloys using scandium products from our flagship Crater Lake Scandium-Rare Earth development project,” said Imperial interim CEO Alain Bureau. “Albecour’s leadership in the production and sale of primary aluminum metal through its partnership at the Aluminerie Alouette aluminium plant in Sept-Iles, Québec will contribute to open global marketing channels for our alloy products. The Parties will cooperate as a team for the purpose of pursuing the Project, including evaluating project viability, determining necessary technological steps to alloy production, and execution of the Project.”

“Albecour is excited to be working with Imperial on this Project to further develop value-added products using scandium for low-carbon aluminium production within Québec’s ecosystem.” said Nicolas Dalmau, Albecour Vice-President Operations & General Manager.


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.